UCBs transformation into a biopharma company is complete.

The Biopharma Advancement Solutions unit focuses on preparing the company’s medium-term growth. One of the important goals of the united team is to build up the wealthy late-stage pipeline, with phase 3 tasks such as for example romosozumab in post-menopausal osteoporosis, epratuzumab in systemic lupus erythematosus and brivaracetam in epilepsy. The unit is usually led by Iris Loew-Friedrich, Executive Vice President, Biopharma Advancement Solutions and Chief Medical Officer, who also coordinates all of UCB’s medical functions.

AOA honors Medical University of Georgia student with Kuckein Fellowship Students at the Medical University of Georgia at Georgia Health Sciences University is among 47 recipients of the 2015 Carolyn L. Kuckein Student Analysis Fellowship from the nationwide medical honor culture Alpha Omega Alpha. The $5,000 award is normally enabling Puja Chebrolu to spend her summer season pouring over a huge federal database in order to help predict kidney dialysis sufferers’ risk of bacteremia, a lethal infection potentially.AOA honors Medical University of Georgia student with Kuckein Fellowship Students at the Medical University of Georgia at Georgia Health Sciences University is among 47 recipients of the 2015 Carolyn L. Kuckein Student Analysis Fellowship from the nationwide medical honor culture Alpha Omega Alpha. The $5,000 award is normally enabling Puja Chebrolu to spend her summer season pouring over a huge federal database in order to help predict kidney dialysis sufferers’ risk of bacteremia, a lethal infection potentially.